about
The role of glutamine oxoglutarate aminotransferase and glutamate dehydrogenase in nitrogen metabolism in Mycobacterium bovis BCG.Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress.A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus.Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.Ergothioneine is a secreted antioxidant in Mycobacterium smegmatisDeletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulentThe distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages.Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections.A unique PE_PGRS protein inhibiting host cell cytosolic defenses and sustaining full virulence of Mycobacterium marinum in multiple hosts.The diverse family of MmpL transporters in mycobacteria: from regulation to antimicrobial developments.Azide-alkyne cycloaddition en route to 4-aminoquinoline-ferrocenylchalcone conjugates: synthesis and anti-TB evaluation.Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish.Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members.MAB_3551c encodes the primary triacylglycerol synthase involved in lipid accumulation in Mycobacterium abscessus.Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid TransportIdentification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus.Cyclipostins and Cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.1H-1,2,3-triazole-tethered uracil-ferrocene and uracil-ferrocenylchalcone conjugates: Synthesis and antitubercular evaluation.Structural rearrangements occurring upon cofactor binding in the Mycobacterium smegmatis β-ketoacyl-acyl carrier protein reductase MabA.Glycopeptidolipids, a Double-Edged Sword of the Mycobacterium abscessus Complex.MmpL8 controls virulence and production of a previously unknown glycolipid familyMutations in the MAB_2299c TetR regulator confer cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessusDelineating the Physiological Roles of the PE and Catalytic Domains of LipY in Lipid Consumption in Mycobacterium-Infected Foamy MacrophagesLsr2 Is an Important Determinant of Intracellular Growth and Virulence inNitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluationScratching the Surface: Bacterial Cell Envelopes at the NanoscaleThe endogenous galactofuranosidase GlfH1 hydrolyzes mycobacterial arabinogalactanMechanical Forces between Mycobacterial Antigen 85 Complex and FibronectinHow microbes use force to control adhesion1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosisThe TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessusFast chemical force microscopy demonstrates that glycopeptidolipids define nanodomains of varying hydrophobicity on mycobacteriaWhat makes bacterial pathogens so sticky?Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages
P50
Q35075765-E01D8699-46FE-42B7-80CE-4E176F182B7AQ35908562-111517F3-28F8-4018-A833-D2C7CF3CEF57Q36001167-E38BA072-8BCF-472B-B882-DC56C0BFF1B7Q36251994-BE95609C-D742-4C99-9D87-F61FE5E95E6FQ36969667-B3CE97A4-401C-4D58-B0ED-314BEC7192D2Q37126863-E98D1B1D-7856-4AF8-894A-1E46113D5DC0Q37464141-EEB4F200-204D-4F5E-90EC-9B7B24D6BAD7Q38701533-89527977-5BE3-45BD-B89B-2597474A695EQ38737962-F920232D-FEBA-4508-B276-5E30395725E7Q39199131-08E08366-81C6-4BC0-AD00-86633BB03D45Q40068100-4B199F54-CC6F-4DD5-A614-B4DDFE6C9BEAQ40093529-1F46410D-D659-4F80-9028-C2670542DBC3Q40300748-415216AA-B543-44DA-82E6-D9C4DA409124Q40579776-F6789BEC-E233-4FB3-9AEB-ADC6208C9035Q41619575-D6486171-FCF3-491E-8C54-7AC6E9E2EAAFQ47654478-EDE42616-0CC6-426C-9D3E-8D8F74793753Q48550005-BACF8DA9-064E-424C-8A72-2446284E318CQ51098218-537742B5-741E-4BB9-9637-1B1B565E4D60Q53826990-7BA824EA-D614-4868-AD36-EAB71B6A1C28Q55323579-96AA7137-4996-4E6B-AE26-B9D8C21420EFQ57292167-9173B64F-A989-4ECB-86E6-1CBF5C86672EQ57832878-2F594185-22BE-449A-8693-90666C25CC26Q58822097-38FCAA65-BB56-4C70-B3D7-E92C3EE374A6Q64078820-E0334D65-227B-422D-BC2C-4DE8503B5F9DQ64882245-1FF73883-A251-4665-87E0-BA2ED03DDE92Q88090978-9D6C1CED-C6AC-4832-AB71-25356DB11AA7Q89881624-8C5EEC71-3C67-469D-9821-E6285DC31700Q89926088-201B6D57-FE37-4982-BEDE-44F044C860E8Q90399208-FCE1BC7D-1D17-42CA-A05E-15A80DFE3327Q91611278-EDCF1C36-3DD3-480F-9EBE-7A51C8517DBDQ92091359-521C20F0-1180-475D-B4D5-738A3B6152F3Q92091413-B9E6135E-22E9-4463-B183-4C5D3C973CE4Q92110381-F4A067A5-AB67-4315-81DF-99FEA97063CBQ92509417-0EF826BC-BD8F-4BCB-B5F4-F7B831A9A9B1Q92823716-E8CE6976-113C-4E24-AB85-FA677C09BB0B
P50
description
onderzoeker uit Zuid-Afrika
@nl
researcher
@en
südafrikanischer Forscher
@de
հետազոտող
@hy
name
Albertus Viljoen
@ast
Albertus Viljoen
@en
Albertus Viljoen
@es
Albertus Viljoen
@nl
type
label
Albertus Viljoen
@ast
Albertus Viljoen
@en
Albertus Viljoen
@es
Albertus Viljoen
@nl
prefLabel
Albertus Viljoen
@ast
Albertus Viljoen
@en
Albertus Viljoen
@es
Albertus Viljoen
@nl
P106
P1153
56007145200
P21
P31
P496
0000-0001-8949-7401